about
Depressogenic effects of medications: a reviewResearch in Parkinson's disease in India: A review.Quality of life in Parkinson's diseaseDysarthria in individuals with Parkinson's disease: a protocol for a binational, cross-sectional, case-controlled study in French and European Portuguese (FraLusoPark).Potential Benefit of Singing for People with Parkinson's Disease: A Systematic Review.A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.The dysarthria impact profile: a preliminary French experience with Parkinson's disease.The association between fear of falling and quality of life for balance impairments based on hip and ankle strategies in the drug On- and Off-phase of patients with idiopathic Parkinson' diseaseHealth-related quality of life in adults with epilepsy: the effect of age, age at onset and duration of epilepsy in a multicentre Italian studyDrug treatment of non-motor symptoms in Parkinson's disease.Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veteransRisk of sleep-disordered breathing in Parkinson's diseaseMajor depressive disorder in Parkinson's disease: a cross-sectional study from Sri LankaReview: management of Parkinson's disease.Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.Deep brain stimulation and responsiveness of the Persian version of Parkinson's disease questionnaire with 39-itemsNeurobiology of depression and anxiety in Parkinson's diseaseAnxiety and Depression Are Better Correlates of Parkinson's Disease Quality of Life Than Apathy.Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability.What are the determinants of quality of life in people with cervical dystonia?The relative health related quality of life of veterans with Parkinson's disease.Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles.The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson's disease.Impact of anxiety on quality of life in Parkinson's disease.Stress, depression and Parkinson's disease.Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilizationAntidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sampleTreatment of behavioural symptoms and dementia in Parkinson's disease.A matter of motion or an emotional matter? Management of depression in Parkinson's disease.Specific impairments in the recognition of emotional facial expressions in Parkinson's disease.Management of the behavioral aspects of Parkinson's disease.Beneficial effect of pramipexole for motor function and depression in Parkinson's disease.Associated and predictive factors of depressive symptoms in patients with Parkinson's disease.Depression in patients with Parkinson's disease: identification and treatment.The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PDThe under-recognition of depression in Parkinson's disease.Latent growth-curve analysis reveals that worsening Parkinson's disease quality of life is driven by depression.Predictors of health status in nondepressed and nondemented individuals with Parkinson's disease.Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?Gender influence on selection and outcome of deep brain stimulation for Parkinson's disease.
P2860
Q24635465-CBBA9327-F6E7-4C5D-A855-3830B98E772EQ26751786-C9473039-C5B0-4087-B23A-C1B8B79A46C6Q26849637-E4535864-3F50-4830-84C3-81186BEB6C91Q30368449-B802A12B-0A43-4242-90FE-8B731BC36B8DQ30388888-CF36471A-4071-419D-8872-9446DEF884D8Q30419918-C99BB830-45EE-42CC-ADD5-734DFF3D9F76Q30453558-37ECCAE9-1607-4C3D-8EBC-57F7FC0DF8D4Q33642301-EC018D60-0298-4E53-8376-E4C6EEB213B8Q33842895-38992BAB-786B-4678-8742-CA8FBD8C7BC0Q34122222-6408D472-1B6C-4603-AFF0-D67104EAD0AFQ34128695-43C38C56-4B79-4ACD-AA39-19401B2D58D8Q34299945-1E627D0F-FC3D-461F-B829-5F76E4930304Q34302897-ACCD6608-A0B1-4D28-BB96-8FC719422BEAQ34332812-80727855-F070-4375-A04F-561AA1EA40A5Q34733143-EFD0E77A-5A65-43AF-8AA9-056E7808BE3DQ34991569-F552E926-686E-49C3-A0AF-4B29118C2B8AQ35028706-58600590-99EC-4610-AD1F-CFA9A0DCDA45Q35130761-08BD3DA2-2B80-41BD-8AA7-0CEE3AC3F4F4Q35205344-73103C97-A55F-47A9-B3DD-48FE64D9B94EQ35466924-A6435A5F-ED9C-4DE5-9F6A-3906AB293227Q35471560-BAF2033D-7A8F-4910-A465-718CF37316E1Q35473731-13B28A38-A9F1-4BF6-AAFE-2A7A7AC9D8D7Q35482058-62174C69-2638-47B5-B632-8A2CB22DDC1AQ35609023-8CE4C681-E23E-4E19-B549-C3C13AF6A4AEQ35713356-78092717-562A-4EFF-9D32-AE13DB41130FQ36024004-1A985C7D-7700-4CF0-83FF-C03FD2F3554FQ36026290-12BDD27B-2804-4145-B6B2-5981C6451452Q36089350-76AE0489-7F75-49E4-965A-E676E577E433Q36307871-905D3D7E-0C57-409D-BD13-7BD44604E466Q36800921-24CD1547-C6B5-45C5-A265-A5EC2525D455Q36847271-938DB083-1B1F-4E2B-B65A-76A28CE1424AQ36876408-53C0823A-B40D-467D-8DF1-D92E92B013AFQ36969544-84917093-CF10-4246-A4EB-D03897BB8D74Q36978002-DB3C19F9-A3CF-41EF-A8D8-A1C0EB9843E6Q37129850-AF7BA85A-7486-4467-BD08-0B64720DC9A3Q37165693-5C6004B0-D761-4234-860C-5E2E716145DEQ37283381-B158A220-E167-438D-9555-BFF88D54BD08Q37406585-82E40BBA-A1BC-47E3-9A49-749BE000C87CQ37514014-65A69CE2-D86E-4758-ABB2-EC2DC19E326CQ37712144-E4464050-D3BE-45A1-8E01-C0D9E9DB099B
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The quality of life in Parkinson's disease.
@en
The quality of life in Parkinson's disease.
@nl
type
label
The quality of life in Parkinson's disease.
@en
The quality of life in Parkinson's disease.
@nl
prefLabel
The quality of life in Parkinson's disease.
@en
The quality of life in Parkinson's disease.
@nl
P2093
P2860
P1433
P1476
The quality of life in Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-#
P407
P577
2000-03-01T00:00:00Z